2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid | CAS:126120-85-2

We serve 2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid CAS:126120-85-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid

Chemical Name:2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid
CAS.NO:126120-85-2
Synonyms:2,2-Difluorobenzo[d][1,3]dioxole-4-carboxylic acid; 
2,2-difluoro-2H-1,3-benzodioxole-4-carboxylic acid;
Molecular Formula:C8H4F2O4
Molecular Weight:202.11200
 
Physical and Chemical Properties:
Density:1.66;
Melting point:202-205oC;
Boiling point:260.8oC;
Flash point:111.5oC;
Index of Refraction:1.561;
 
Specification:
Appearance:Off-white solid
Purity(HPLC):≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate for organic synthesis
 



Contact us for information like 2,2-Difluoro-1,3-benzodioxole-4-carboxylic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,2-difluoro-2H-1,3-benzodioxole-4-carboxylic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2-difluoro-2H-1,3-benzodioxole-4-carboxylic acid Use and application,2,2-Difluorobenzo[d][1,3]dioxole-4-carboxylic acid technical grade,usp/ep/jp grade.


Related News: As part of the agreement, ICIG will enter into a 5-year supply contract to provide Genzyme with materials needed for the production of eliglustat tartrate, an investigational treatment for Gaucher disease Type 1 that is currently in Phase III clinical trials.L-Ornithine Monohydrochloride manufacturer Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.10,10-Dimethylanthrone supplier Zhejiang Huahai Pharmaceutical: It is a leading company in domestic APIs, especially in the field of cardiovascular drugs.2-chloro-1-fluoro-4-isothiocyanatobenzene vendor DPH and BPHC continue to work closely with the CDC to maintain vigilance during this virus outbreak.By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.